European Association for the Study of the Liver Press Releases - EIN Presswire

Published on April 14, 2022 - 12:19 GMT

Europe’s leading hepatology conference, ILC 2022, to be held in-person in London, UK

Impact of the pandemic on alcohol-related liver disease and liver transplantation, and NAFLD as an emerging public health threat to be featured at ILC 2022. GENEVA, SWITZERLAND, April 14, 2022 /⁨EINPresswire.com⁩/ -- The latest and 57th iteration of …

Distribution channels: Conferences & Trade Fairs, Education ...

Published on December 2, 2021 - 11:00 GMT

The EASL-Lancet Commission calls for a paradigm shift in the liver disease response in Europe

Liver disease is now the second leading cause of years of working life lost in Europe BRUSSELS, BELGIUM, December 2, 2021 /⁨EINPresswire.com⁩/ -- The future health of Europeans is inextricably related to a fundamental shift in the way in which liver …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 25, 2021 - 13:00 GMT

Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021

Breakthrough drug for Europe´s fastest growing disease announced at the International Liver Congress 2021 GENEVA, SWITZERLAND, June 25, 2021 /⁨EINPresswire.com⁩/ -- For Immediate Release Media Release Treatment advances for Non-Alcoholic Fatty …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 24, 2021 - 13:00 GMT

Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021

New treatment for liver cancer announced at ILC 2021 GENEVA, SWITZERLAND, June 24, 2021 /⁨EINPresswire.com⁩/ -- For Immediate Release Media Release Advances in new drugs to for curing Hepatitis B and Hepatitis D announced at ILC 2021 Leading …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 23, 2021 - 13:00 GMT

ILC 2021 opens with focus on impact of COVID-19 on global liver disease

People living with advanced liver disease not protected by Pfizer-BioNTech COVID-19 vaccine GENEVA, SWITZERLAND, June 23, 2021 /⁨EINPresswire.com⁩/ -- For Immediate Release Media Release ILC 2021 opens with focus on impact of COVID-19 on global …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 21, 2021 - 13:00 GMT

Effectiveness of COVID-19 vaccine for people living with advanced liver disease to open ILC 2021

Elderly with advanced liver fibrosis had lower response to Pfizer-BioNTech´s SARS-CoV-2 vaccine response: breaking study to open ILC 2021 GENEVA, SWITZERLAND, June 21, 2021 /⁨EINPresswire.com⁩/ -- Media Advisory For Immediate Release Elderly with …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on June 9, 2021 - 14:35 GMT

Effectiveness of COVID-19 vaccines for people with advanced liver disease features at International Liver Congress 2021

GENEVA, SWITZERLAND, June 9, 2021 /⁨EINPresswire.com⁩/ -- Breakthrough studies on the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Hepatitis D to be announced at the conference Tuesday, 8th June 2021 (Geneva, Switzerland)--The impact of the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...